Selegiline hydrochloride - Parkinson's disease (neuroprotective therapy)
You are here : Home > Formulary Search > Selegiline hydrochloride - Parkinson's disease (neuroprotective therapy)
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
Guidelines (National)
PAD Profile
ChemicalSubstance :
Selegiline hydrochloride
Indication :
Parkinson's disease (neuroprotective therapy)
Group Name :
Keywords :
dopamine agonists, Parkinsons disease, PD, monoamine-oxidase-B inhibitors, MAOB
Brand Names Include :
Eldepryl, Zelapar
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Other Indications
Below are listed other indications that Selegiline hydrochloride is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Parkinson's disease (neuroprotective therapy).
Committee Recommendations (1)
Monoamine-oxidase-B inhibitors (rasagiline, selegiline) are not recommended as a neuroprotective therapy except in the context of a clinical trial.